90岁及以上人群用药:一项全国性研究
该研究利用法国国家健康数据系统2022年数据,纳入696,498名90岁及以上参保者,描述其用药、多重用药(≥5种)和超多重用药(≥10种)情况。结果显示77.7%存在多重用药,最常处方为降压药(73.8%)、镇痛药(58.8%)、抗血栓药(55.3%)、维生素D(51.1%)和精神药物(42%)。随年龄增长预防性药物减少而症状管理药物增加,养老院居民更易使用精神药物而较少使用心血管药物。
要点
- 90岁及以上人群多重用药(≥5种)比例达77.7%,最常用为降压药、镇痛药和抗血栓药。
- 随年龄增长预防性药物处方减少、症状管理药物增加,但降幅可能不足。
- 养老院居民精神药物使用更多、心血管药物使用更少,应考虑短预期寿命下的减药。
核心结论
- 90岁及以上人群某些药物随年龄增长呈渐进性但可能不足的减少,养老院中减少程度更弱,应在短预期寿命背景下讨论停药以避免多重用药危害。
研究设计与样本
- cohort研究,使用法国国家健康数据系统2022年数据,纳入隶属于一般保险计划的90岁及以上人群共696,498人。
- 按性别、年龄组(90-94岁、95-99岁、≥100岁)和居住地描述用药,因死亡率高而按季度分析。
主要发现
- 纳入人群中73.2%为女性,75.9%为90-94岁,2.9%为≥100岁;77%处方高血压治疗,50.4%有心血管疾病,17.7%有痴呆。
- 第一季度的多重用药(≥5种)比例为77.7%。
- 最常处方药物为降压药(73.8%)、镇痛药(58.8%)、抗血栓药(55.3%)、维生素D(51.1%)和精神药物(42%)。
- 随年龄增长预防性药物减少而症状管理药物增加;养老院居民更可能使用精神药物、较少接受心血管药物;其他季度结果类似。
关键数值与推荐
- 多重用药定义为≥5种药物,超多重用药定义为≥10种药物。
- 年龄分组为90-94岁、95-99岁、≥100岁。
临床怎么用
- 对90岁及以上患者应评估多重用药,结合短预期寿命讨论预防性药物停用,避免多重用药危害。
- 养老院居民需关注精神药物使用过多和心血管药物使用不足的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to describe the medications prescribed to people aged ≥90 years. DESIGN: A cohort study was performed using data from the year 2022. SETTING AND PARTICIPANTS: Using data from the French National Health Data System, people aged ≥90 years affiliated with the general insurance scheme were included. METHODS: Medications dispensed, polypharmacy (≥5 drugs), and hyperpolypharmacy (≥10 drugs) were described in the total population and according to sex, age group (90-94 years, 95-99 years, ≥100 years), and place of residence. All analyses were conducted by quarter because of the high mortality rate in this population. RESULTS: In total, 696,498 subjects were included in the study. Among them, 73.2% were women, 75.9% were aged 90-94 years, and 2.9% were ≥100 years. Treatment for hypertension was prescribed to 77%, 50.4% had cardiovascular disease, and 17.7% had dementia. During the first quarter, 77.7% experienced polypharmacy. The most prescribed drugs were antihypertensive medications (73.8%), analgesics (58.8%), antithrombotics (55.3%), vitamin D (51.1%), and psychotropics (42%). There was a decrease in preventive drugs and an increase in symptom management drugs with increasing age. Subjects in nursing homes were more likely to take psychotropics and less likely to receive cardiovascular drugs. The results for the other quarters were similar. CONCLUSIONS AND IMPLICATIONS: Our results suggest a progressive, but probably insufficient decrease in the prescription of certain medications with age and to a lesser extent, in nursing homes. The discontinuation of treatments should be discussed in the context of short life expectancy to avoid the harmful effects of polypharmacy.
引用
- Kanagaratnam L, Semenzato L, Baudouin EP, et al. Medication Use in People Aged 90 Years and Older: A Nationwide Study. J Am Med Dir Assoc. 2025. PMID: 39805323. doi:10.1016/j.jamda.2024.105459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。